Comparison of the effect of oxelidine and sufentanil equivalent dose in hysteroscopic surgery

Comparison of the effect of oxelidine and sufentanil equivalent analgesic dose in hysteroscopic surgery

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2400091785

Enrollment

Unknown

Registered

2024-11-04

Start date

2024-11-04

Completion date

Unknown

Last updated

2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uterine lesion

Interventions

Oxeridine:Oxelidine 30ug/kg was administered intravenously 3min before operation, propofol 2mg/kg intravenously 1min before operation, and propofol 3-6 mg/(kg·h) was continuously injected intravenousl

Sufentanil:Sufentanil 0.1ug/kg was injected intravenously 3min before operation, propofol 2mg/kg intravenously 1min before operation, and propofol 3-6 mg/(kg·h) was continuously injected intravenously

Eligibility

Sex/Gender

Female

Age

18 Years to 64 Years

Inclusion criteria

Inclusion criteria: 1. Age 18-64 years old; 2. Hysteroscopic elective surgery under quasi-intravenous anesthesia 3.ASA Grade ? or ?; 4.BMI 18.5 ~ 23.9 kg/m^2

Exclusion criteria

Exclusion criteria: 1. Allergic to propofol and other drugs involved in this study; 2. Have a mental illness or take antipsychotic drugs 3. Patients who are deaf, mute, or unable to communicate and cooperate with this experiment; 3. Pregnancy or breastfeeding; 4. Long-term use of sedative and analgesic drugs

Design outcomes

Secondary

Measure	Time frame
Total amount of propofol;Pain score after operation;	—

Countries

China

Contacts

Public ContactQian Bin

Yancheng First People's Hospital

13770008797@163.com+86 137 7000 8797

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026